Bristol Myers Squibb (CELG-RI) Buildings (2015 - 2026)

Bristol Myers Squibb has disclosed Buildings across 12 years of filings, most recently posting $7.5 billion for Q1 2026.

• In Q1 2026, Buildings rose 12.74% year-over-year to $7.5 billion; the TTM figure through Mar 2026 stood at $7.5 billion (up 12.74% YoY), while the FY2025 annual figure was $7.3 billion, up 10.47% from the prior year.
• Buildings climbed to $7.5 billion in Q1 2026, from $7.3 billion in the prior quarter.
• Over the last five years, Buildings for CELG-RI reached as high as $7.5 billion in Q1 2026 and fell as low as $5.7 billion in Q2 2022.
• The 5-year median for Buildings is $6.5 billion (2023), against an average of $6.5 billion.
• Annual changes were most pronounced in 2022 — Buildings climbed 0.09% — and 2026, when it gained 12.74%.
• A 5-year view of Buildings shows it stood at $5.9 billion in 2022, then increased by 9.71% to $6.5 billion in 2023, then rose by 1.32% to $6.6 billion in 2024, then rose by 10.47% to $7.3 billion in 2025, then rose by 2.97% to $7.5 billion in 2026.
• According to Business Quant data, Buildings over the past three periods registered $7.5 billion, $7.3 billion, and $7.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.